Save time and get answers to complex questions with AI chat
Dabrafenib mesylate when the patent is expiring in india?Can i take anti histamine with statin?Prolia and osteonecrosis?When will a generic version of xiaflex be available?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?
See the DrugPatentWatch profile for Pirfenidone
Pirfenidone is an oral antifibrotic agent used for idiopathic pulmonary fibrosis (IPF). It is classified as an anti-fibrotic medicine.
Pirfenidone is used in patients with idiopathic pulmonary fibrosis (IPF), a chronic, progressive lung scarring (fibrosis) disease.
As an antifibrotic drug, pirfenidone works to slow or reduce the processes that lead to lung tissue scarring. Its therapeutic use is tied to that anti-fibrosis effect in IPF.
Other Questions About Pirfenidone :